You Don’t Have to Live With Back Pain

You have probably noticed the pattern by now. Physical therapy first. Then medication. Then a steroid injection, which helps for a while. Then another. And eventually, when the injections stop working, someone brings up fusion.

You are not imagining that sequence. It is remarkably consistent from patient to patient, and it is worth understanding why — because the logic that drives it is not the same as the logic that would resolve your pain.

The staircase you have been climbing

Look at the standard pathway as a whole rather than one step at a time.

Physical therapy comes first, which is reasonable. Then pills, which manage the sensation of pain without touching what generates it. Then steroid injections — and here is the part that rarely gets said plainly: steroids accelerate tissue breakdown. The relief is real, and so is the cost to the tissue receiving it. Each round buys less time than the one before.

And when that ladder runs out, the last rung is spinal fusion — an operation that fails up to 56% of the time in the lumbar spine.

That is not a rare complication. That is closer to a coin flip, offered as the definitive answer at the end of a pathway that has already cost you years.

Why the pathway looks the way it does

This is not about any individual physician. The doctors moving you through those steps are, for the most part, doing exactly what the system trained and reimburses them to do.

The problem is structural. The pathway is built around suppressing the signal — the pain — rather than resolving what produces it. Every step is a legitimate, billable intervention. None of them is designed to make the tissue functional again. A system organized that way does not need to conspire against you to keep you coming back; it simply has no built-in exit.

What it does not do is ask the question that actually matters: why is this tissue failing to repair itself?

What root-cause treatment actually involves

Resolving pain at its root means addressing both the damaged structure and the biological environment it lives in. In practice, at Regen.MD, that means several things working together.

Interventional orthobiologics. Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) are delivered to the tissue that needs repair signaling. The delivery matters as much as the material: placement with millimeter precision under fluoroscopy and ultrasound guidance is a fundamentally different intervention from a landmark-based injection, however skilled the hand performing it.

The metabolic edge. This is the piece most patients have never had explained. Insulin resistance and meta-inflammation quietly sabotage every treatment you have already tried. If your metabolic terrain is inflamed and dysregulated, the tissue is being asked to rebuild in an environment that will not permit it. That is why an injection can be technically perfect and biologically inert. Preparing the terrain is not an add-on — it is what makes the rest capable of working.

Electronic Signal Therapy (EST). This applies piezoelectric principles to support the regeneration of nerve and tissue — using signal, not pharmacology, to influence how tissue behaves.

Measurement instead of guesswork. Recovery is tracked in real time with Measura.ai, proprietary technology built for exactly that purpose. If a treatment is not producing change, that should be visible in data rather than inferred from a conversation months later.

Care delivered outside the hospital. Regen.MD operates an 18,000 square foot Center of Excellence in St. Louis. Doing the work there rather than in a hospital setting avoids the facility overhead that quietly adds thousands to the cost of care for St. Louis patients.

What this means for the decision in front of you

Nothing here says that surgery is never appropriate. Sometimes it is genuinely the right operation for the right patient at the right time.

What it says is that a 56% lumbar fusion failure rate is a number that deserves to sit in front of you before you consent, not after. And that the pathway leading to that decision — years of pills and steroids that accelerated the breakdown of your tissue — may have made your spine a worse surgical candidate along the way.

Whether you are a candidate for a regenerative approach is a clinical question. It depends on your imaging, your examination, your metabolic markers, and your history. That is what a formal evaluation is for. Before an irreversible decision, an evaluation is not a delay — it is due diligence.

Frequently asked questions

Key takeaways

• The standard back pain pathway runs physical therapy to pills to steroid injections to fusion, and each step suppresses the signal rather than resolving its source.
• Steroid injections accelerate tissue breakdown, which is why the relief they give shortens with each round.
• Lumbar spinal fusion fails up to 56% of the time — a number that belongs in the conversation before consent, not after.
• Regenerative care combines precisely guided orthobiologics with metabolic optimization, because an injection cannot outperform the environment it lands in.
• Whether any of this applies to your spine is a clinical question requiring imaging, examination, and metabolic assessment.

Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician. Orthobiologic therapies including PRP and bone marrow aspirate concentrate are not FDA-approved for this indication and are provided as part of physician-directed care.